Download PDF
1 / Pages

Other users also viewed these articles

The reality of Rheumatology in Spain and its autonomous communities before the pandemic Carlos Sánchez-Piedra; José María Álvaro-Gracia; Sagrario Bustabad-Reyes; Federico Díaz-González;
Reumatol Clin. 2022;18:486-9
Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study* Francisco J. Blanco; Maite Silva-Díaz; Víctor Quevedo Vila; Daniel Seoane-Mato; Fernando Pérez Ruiz; Antonio Juan-Mas; José M. Pego-Reigosa; Javier Narváez; Neus Quilis; Raúl Cortés; Antonio Romero Pérez; Dolores Fábregas Canales; Teresa Font Gayá; Carolina Bordoy Ferrer; Carlos Sánchez-Piedra; Federico Díaz-González; Sagrario Bustabad-Reyes;
Reumatol Clin. 2021;17:461-70
Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis? Ana Martins; Sofia Pimenta; Daniela Oliveira; Rafaela Nicolau; Alexandra Bernardo; Teresa Martins Rocha; Lúcia Costa; Miguel Bernardes;
Reumatol Clin. 2024;20:380-5